The AHPBA Podcast Timothy Vreeland

El Dr. Molina se graduó de la Universidad Johns Hopkins con una licenciatura en biología celular y molecular. Obtuvo su título de médico en la Facultad de Medicina de Harvard y completó una maestría en Métodos Cuantitativos en la Escuela de Salud Pública T. H. Chan de Harvard. Realizo residencia en Cirugía General en el Hospital General de Massachusetts (MGH) y una beca en Oncología Quirúrgica General Compleja en el Hospital Brigham and Women's/MGH y el Instituto del Cáncer Dana-Farber. Con el Dr Molina, conversamos de su trabajo en Ariadne Labs, Blackbox y mucho mas. Espero disfruten la entrevista!

Today’s episode is a special in-person interview with Dr. Newhook and Dr. Bas Groot Koerkamp!  Dr. Koerkamp is a hepatobiliary surgeon and researcher within the HPB and Transplantation Surgery department of Erasmus University Medical Center in Rotterdam, Netherlands.  Dr. Groot Koerkamp leads several national clinical studies with the Dutch Pancreatic Cancer Group, including the PREOPANC studies, which we are thrilled to discuss in today’s episode!  Enjoy!
 
Papers Referenced in the Episode:
Versteijne E, van Dam JL, Suker M, Janssen QP, Groothuis K, Akkermans-Vogelaar JM, Besselink MG, Bonsing BA, Buijsen J, Busch OR, Creemers GM, van Dam RM, Eskens FALM, Festen S, de Groot JWB, Groot Koerkamp B, de Hingh IH, Homs MYV, van Hooft JE, Kerver ED, Luelmo SAC, Neelis KJ, Nuyttens J, Paardekooper GMRM, Patijn GA, van der Sangen MJC, de Vos-Geelen J, Wilmink JW, Zwinderman AH, Punt CJ, van Tienhoven G, van Eijck CHJ; Dutch Pancreatic Cancer Group. Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial. J Clin Oncol. 2022 Apr 10;40(11):1220-1230. doi: 10.1200/JCO.21.02233. Epub 2022 Jan 27. PMID: 35084987.
Janssen, Q.P., van Dam, J.L., Bonsing, B.A. et al.Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial. BMC Cancer 21, 300 (2021). https://doi.org/10.1186/s12885-021-08031-z
Janssen, Q., van Dam, J. L., Besselink, M. G., Homs, M. Y., van Tienhoven, G., Wilmink, J. W., ... & Dutch Pancreatic Cancer Group. (2021). Total neoadjuvant FOLFIRINOX or gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2): A nationwide multicenter randomized controlled trial.
Janssen QP, van Dam JL, Bonsing BA, Bos H, Bosscha KP, Coene PPLO, van Eijck CHJ, de Hingh IHJT, Karsten TM, van der Kolk MB, Patijn GA, Liem MSL, van Santvoort HC, Loosveld OJL, de Vos-Geelen J, Zonderhuis BM, Homs MYV, van Tienhoven G, Besselink MG, Wilmink JW, Groot Koerkamp B; Dutch Pancreatic Cancer Group. Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial. BMC Cancer. 2021 Mar 23;21(1):300. doi: 10.1186/s12885-021-08031-z. PMID: 33757440; PMCID: PMC7989075.
Versteijne E, Suker M, Groothuis K, Akkermans-Vogelaar JM, Besselink MG, Bonsing BA, Buijsen J, Busch OR, Creemers GM, van Dam RM, Eskens FALM, Festen S, de Groot JWB, Groot Koerkamp B, de Hingh IH, Homs MYV, van Hooft JE, Kerver ED, Luelmo SAC, Neelis KJ, Nuyttens J, Paardekooper GMRM, Patijn GA, van der Sangen MJC, de Vos-Geelen J, Wilmink JW, Zwinderman AH, Punt CJ, van Eijck CH, van Tienhoven G; Dutch Pancreatic Cancer Group. Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial. J Clin Oncol. 2020 Jun 1;38(16):1763-1773. doi: 10.1200/JCO.19.02274. Epub 2020 Feb 27. PMID: 32105518; PMCID: PMC8265386.
https://www.facs.org/for-medical-professionals/news-publications/news-and-articles/bulletin/july-2022-volume-107-number-7/alliance-a021806-a-phase-iii-trial-of-perioperative-vs-adjuvant-chemotherapy-for-resectable-pancreatic-cancer/
Franssen, S., Van Driel, L. M., Moelker, A., & Groot Koerkamp, B. (2023). Primary percutaneous stenting above the ampulla for palliative biliary drainage of malignant hilar biliary obstruction.

Join us for the second episode of our series ECG Overtime, hosted by the E-AHPBA/IHPBA Early Career Group!  This episode features Dr. Leanne Prodehl, Dr. Sanket Srinivasa, Dr. Rachel Moore, and Dr. Niki Rashidian.  Join us in continuing a conversation from the ECG Roadshow—starting a robotic HPB program and collaborating on multicenter research projects!     

Today’s episode features Dr. Ching-Wei Tzeng.  Dr. Tzeng is a hepatobiliary surgeon and Associate Professor of Surgical Oncology at MD Anderson.  Among many roles, he is the Department Vice Chair of Clinical Operations and Program Director for the HPB Surgery Fellowship.
Dr. Tzeng is an accomplished researcher.  His interests focus on multimodality therapy for GI Cancers and perioperative quality improvement, including cancer surgery standards, patient-centered opioid reduction protocols, and quality of life measures.  Dr. Tzeng is a passionate surgical educator and has been widely recognized with numerous teaching awards.
In this episode we discuss topics including surgical education, quality improvement from the surgeon to institution level, and much more.  Enjoy!
Papers/Trials Referenced in the Episode:
DiPeri TP, Newhook TE, Arvide EM, Dewhurst WL, Bruno ML, Chun YS, Tran Cao HS, Lee JE, Vauthey JN, Tzeng CD. Prospective Implementation of Standardized Post-Hepatectomy Care Pathways to Reduce Opioid Prescription Volume after Inpatient Surgery. J Am Coll Surg. 2022 Jul 1;235(1):41-48. doi: 10.1097/XCS.0000000000000231. Epub 2022 Apr 11. PMID: 35703961; PMCID: PMC9205619.
Day RW, Newhook TE, Dewhurst WL, Arvide EM, Bruno ML, Vauthey JN, Tzeng CD. Assessing the 5×-Multiplier Calculation to Reduce Discharge Opioid Prescription Volumes After Inpatient Surgery. JAMA Surg. 2020 Dec 1;155(12):1166-1167. doi: 10.1001/jamasurg.2020.3527. PMID: 32997105; PMCID: PMC7527936.
Preoperative Y90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients with Colorectal Liver Metastases: https://classic.clinicaltrials.gob/ct2/show/NCT05195710

Join us for the first episode of a brand new series within the AHPBA Podcast from the AHPBA/IHPBA Early Career Group, ECG Overtime!  In this episode, Dr. Timothy Newhook, Dr. Kimberly Washington, Dr. Naruhiko Ikoma, and Dr. Giampaolo Perri talk through the most recent ECG webinar topic, the dynamic early-career HPB surgeon!  Enjoy!

Today’s episode features Dr. Majella Doyle.  Dr. Doyle is a transplant surgeon, professor of surgery, and the Mid-America Transplant/Department of Surgery Distinguished Endowed Chair in Abdominal Transplantation at Washington University School of Medicine in St. Louis.  She served as AHPBA president from 2022-2023.
In this episode, we discuss Dr. Doyle’s journey from Ireland to the United States, her entry into robotic surgery, and the care of patients with cholangiocarcinoma.  We hope you enjoy listening as much as we enjoyed the interview! 
 
Papers Referenced in the Episode:
Ethun CG, Lopez-Aguiar AG, Anderson DJ, Adams AB, Fields RC, Doyle MB, Chapman WC, Krasnick BA, Weber SM, Mezrich JD, Salem A, Pawlik TM, Poultsides G, Tran TB, Idrees K, Isom CA, Martin RCG, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Cardona K, Maithel SK. Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease. Ann Surg. 2018 May;267(5):797-805. doi: 10.1097/SLA.0000000000002574. PMID: 29064885; PMCID: PMC6002861.